mGem: Immune recognition and clearance of bacteriophages—implications for phage therapy
mBio · 10.12.2025 · 16 (12)
DOI: 10.1128/mbio.01418-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 10.12.2025. Verfasst von H T Le und 3 weiteren Autor:innen. Beteiligte Einrichtung: Blacktown Clinical School, Western Sydney University, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Bacterial Infections, Bacteriophages, Phage Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacteriophages (phages) hold significant promise as targeted antibacterial therapies in the era of rising multidrug-resistant infections. Despite their therapeutic potential, the clinical application of phages for human infections has been significantly hindered by the rapid and robust immune response to phages in blood. The rapid clearance of >99% of phages from circulation within hours of injection is the result of innate and adaptive immune responses that target therapeutic phage for clearance and destruction. Methodologies must be developed to isolate and/or modify phages that are not only therapeutically potent but also immunologically camouflaged. The resulting second- and third-generation phage therapies will be more effective by evading host immune responses, enabling more efficient targeting of bacterial pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Blacktown Clinical School, Western Sydney University, Sydney, New South Wales, Australia.
- Storr Liver Centre, Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
- Blacktown Mt Druitt Hospital, Sydney, New South Wales, Australia.
- Centre for Infectious Diseases and Microbiology (CIDM), Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
- Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: G Ahlenstiel, C Venturini, S A Read
Zitieren
APA
Le, H. T., Ahlenstiel, G., Venturini, C., & Read, S. A. (2025). mGem: Immune recognition and clearance of bacteriophages—implications for phage therapy. mBio, 16(12). https://doi.org/10.1128/mbio.01418-25
Vancouver
Le HT, Ahlenstiel G, Venturini C, Read SA. mGem: Immune recognition and clearance of bacteriophages—implications for phage therapy. mBio. 2025;16(12). doi:10.1128/mbio.01418-25
BibTeX
@article{Le2025,
author = {Le, H T and Ahlenstiel, G and Venturini, C and Read, S A},
title = {mGem: Immune recognition and clearance of bacteriophages—implications for phage therapy},
journal = {mBio},
year = {2025},
volume = {16},
number = {12},
doi = {10.1128/mbio.01418-25}
}
EUVIMED